J W Ensinck

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

David A. D’Alessio, Steven E. Kahn, C R Leusner et al. · Journal of Clinical Investigation · 1994 · 283 citations · Full text

Healthy Subjects, Glucose Tolerance, Insulin Signaling +19

Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

Jerry P. Palmer, J W Benson, R.M. Walter et al. · Journal of Clinical Investigation · 1976 · 205 citations · Full text

Acute Phase, Insulin Signaling, Metabolic Syndrome +17

Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons.

David A. D’Alessio, R Vogel, Ronald L. Prigeon et al. · Journal of Clinical Investigation · 1996 · 122 citations · Full text

Nutrition, Glucagon Output, Glucose Tolerance +19

Glucagon response to hypoglycemia in sympathectomized man.

Jerry P. Palmer, D P Henry, J W Benson et al. · Journal of Clinical Investigation · 1976 · 111 citations · Full text

Metabolic Syndrome, Adrenal Gland, Glucagon Rise +15

Inhibition of Glucagon and Insulin Secretion by Somatostatin in the Rat Pancreas Perfused<i>in Situ</i>

D. Johnson, J W Ensinck, Donna J. Koerker et al. · Endocrinology · 1975 · 76 citations

Rat Pancreas, Pancreatic Islets, Growth Hormone +9